首页> 外文OA文献 >Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck

【2h】

Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck

机译：与表皮生长因子受体抑制剂在头部和颈部复发性和转移鳞状细胞癌中的临床益处相关的因素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ezra Eddy Wyssam Cohen; Anna B. Halpern; Kristen Kasza; Masha Kocherginsky; Rosalyn Williams; Everett E. Vokes;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. [J] . Cohen EE Journal of Clinical Oncology . 2006,第17期

机译：表皮生长因子受体途径靶向治疗在复发性和/或转移性头颈部鳞状细胞癌患者中的作用。
2. Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck. [J] . Siu LL Journal of Clinical Oncology . 2004,第1期

机译：厄洛替尼是一种口服表皮生长因子受体酪氨酸激酶抑制剂的多中心II期研究，用于头颈部复发或转移性鳞状细胞癌患者。
3. Treatment of squamous cell carcinoma of the head and neck in the metastatic and refractory settings: advances in chemotherapy and the emergence of small molecule epidermal growth factor receptor kinase inhibitors. [J] . Ahmed SM, Cohen EE Current cancer drug targets . 2007,第7期

机译：在转移性和难治性环境中治疗头颈部鳞状细胞癌：化学疗法的进展和小分子表皮生长因子受体激酶抑制剂的出现。
4. The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses Proliferation and Invasion of Human Oral Squamous Carcinoma Cells via p53 Independent and MMP, uPAR Dependent Mechanism [C] . EUN JU LEE, JIN HA WHANG, NAM KYEONG JEON, Meeting on Cell Signaling World: Signal Transduction Pathways as Therapeutic Targets . 2007

机译：表皮生长因子受体酪氨酸激酶抑制剂ZD1839（Iressa）通过独立于p53和MMP，uPAR依赖性机制抑制人口腔鳞状细胞癌细胞的增殖和侵袭
5. The prognostic potential of the epidermal growth factor receptor and nuclear factor kappa B pathways and associated therapeutic strategies in patients with squamous cell carcinoma of the head and neck. [D] . Wirth, Pamela Susan. 2010

机译：表皮生长因子受体和核因子κB通路对头颈部鳞状细胞癌患者的预后潜力及相关治疗策略。
6. Factors Associated with Clinical Benefit from Epidermal Growth Factor Receptor Inhibitors in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck [O] . Ezra Eddy Wyssam Cohen, Anna B. Halpern, Kristen Kasza, -1

机译：与表皮生长因子受体抑制剂在头部和颈部复发性和转移鳞状细胞癌中的临床益处相关的因素
7. Meta-analysis of the effects of anti-epidermal growth factor receptor on recurrent/metastatic head and neck squamous cell carcinoma [O] . Yong Xin, Qiuyue Yan, ChunSheng Yang, 2018

机译：抗表皮生长因子受体对复发/转移头和颈鳞状细胞癌的影响的荟萃分析

Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck

著录项

引文网络

相似文献

相关主题

期刊订阅